Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell ...

Ascentage Pharma Group International (NASDAQ:AAPG) is one of the best young stocks to buy and hold for 5 years.

Cancer Drug Startup Antares Unveils $177M to Pick Up Where Scorpion Therapeutics Left Off Antares Therapeutics spun off of Scorpion Therapeutics, a clinical-stage biotech that Eli Lilly acquired ...

Research from Northwestern University shows how a Pfizer-made drug could double as breast cancer prevention and as a way to treat menopause symptoms.

An "AI scientist," working in collaboration with human scientists, has found that combinations of cheap and safe drugs—used to treat conditions such as high cholesterol and alcohol dependence ...

BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech’s BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.

Bristol Myers Squibb is partnering with BioNTech on a closely watched cancer drug, in a deal worth billions of dollars.

A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved their quality of life.

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases.

Explore how biosimilars are lowering cancer drug costs and reshaping treatment access for patients, providers, and healthcare systems worldwide.

While the drug may not be strong enough to treat colon cancer on its own, researchers believe it could enhance more aggressive therapies when used in combination.

May 9, 2025 -- A new oral cancer drug combination has gained a quick federal nod after clinical trials found that it provides significant and longer-lasting relief for a rare ovarian cancer that ...